Marianthi (Mara) Tatari
About Marianthi (Mara) Tatari
Marianthi (Mara) Tatari is an Applied Drug Discovery Analyst (Senior Scientist) at BenevolentAI and an MSc Student in Bioinformatics at Birkbeck, University of London. She has over ten years of experience in cancer research and has held various research and leadership roles in prominent institutions.
Current Role at BenevolentAI
Marianthi (Mara) Tatari is currently employed as an Applied Drug Discovery Analyst (Senior Scientist) at BenevolentAI. Located in London, England, United Kingdom, her work involves applying advanced analytical methods to drug discovery projects, particularly focusing on the innovative use of AI in the pharmaceutical industry.
Current Education in Bioinformatics
Marianthi is also pursuing a Master of Science in Bioinformatics at Birkbeck, University of London. This academic endeavor aims to equip her with the skills to leverage big data for novel interdisciplinary drug discovery projects, thereby expanding her expertise in the bioinformatics domain.
Past Experience at The Institute of Cancer Research
Previously, Marianthi worked at The Institute of Cancer Research as a Higher Scientific Officer / Biology Lead for three years from 2018 to 2021. Based in Sutton, United Kingdom, her role involved leading biological projects, contributing to cutting-edge cancer research, and managing various scientific undertakings.
Editorial Role at Panacea Innovation
In 2015, Marianthi held the position of Editorial Lead for Panacea Innovation's London Division for a brief period of three months. During this tenure, she was responsible for leading editorial projects, which likely involved the preparation and review of scientific content relevant to innovation in the biotechnology sector.
Extensive Research Background
Marianthi's extensive research career includes roles such as Postdoctoral Research Associate at Barts Cancer Institute from 2014 to 2017, Researcher at CNIO in Madrid from 2013 to 2014, and Post Doctoral Researcher at Albert Einstein College of Medicine from 2012 to 2013. Her research focus spanned various tissues and 3D models in cancer research, contributing over a decade of experience to the field.